Building on Albion VC’s and HLTH Europe foundational HealthTech map, we’ve expanded the scope with Specter’s proprietary data, creating one of the most comprehensive Digital Care Market Maps to date.

We mapped 880+ companies across diagnostics, clinical decision support, telemedicine, remote monitoring, patient engagement, and workflow automation—capturing how digital care is becoming the operating backbone of healthcare delivery in Europe. While B2C apps like symptom checkers and wellness platforms have slowed, enterprise and provider-focused solutions are accelerating, fueled by AI adoption and demand for scalable care infrastructure.

With more than €5bn invested in the past three years into companies featured here, the digital care ecosystem is entering a new growth phase—maturing from fragmented point solutions into critical infrastructure for the next generation of healthcare.

Get The EU HealthTech Landscape!

Already a Specter user? Click here to explore the EU HealthTech Landscape 🩺
Not on Specter yet? Download the list and get in touch to access the full dataset 📥

Download

Chronic Care & Companion Apps

Albert Health (🌟 Specter ‑ Global Rank 31,840)
Voice‑first, evidence‑based companion for multi‑chronic care—medication adherence, remote monitoring, and AI coaching—now operating across TR/UK/MENA. Founded 2018 by Recai Serdar Gemici (CEO), Serhat Uzun (COO), and Ensar Güneşdoğdu (CTO) after prior engineering/strategy roles (e.g., Siemens). Last funding February 18, 2025 — $1.5m (Type: Series Unknown); public reports describe this as a seed round with investors including Sabancı Ventures, Ak Portföy, Maxis, TT Ventures, Eksim Ventures and others. Positioning: voice UI + disease‑specific programs for payers/pharma with real‑world deployments.

Orbit Health (🌟 Specter ‑ Global Rank 40,489)
Neptune pairs Garmin wearables with AI to transform Parkinson’s management—continuous motor‑state insights for clinicians and patients; CE‑certified software. Founded 2021 in Munich by Patty Lee and Dr. Franz M. J. Pfister (physician/data‑scientist). Last funding July 12, 2022 — Non‑Equity Assistance; prior seed closed at €4M (Dec 20, 2021) via MTE, BII, EIT Health. Recent updates include the Garmin collaboration and growth of Neptune Care deployments.

Kalium Health (🌟 Specter ‑ Global Rank 63,742)
University of Cambridge spin‑out developing a home blood‑potassium test and digital platform for cardiorenal patients—aimed at proactive management of hyper/hypokalemia. Co‑founded by clinicians and scientists (e.g., Prof. Fiona Karet) with CEO Tom Collings leading the scale‑up. Last funding June 27, 2023 — Grant $191k; earlier seed £950k (Mar 12, 2020) led by Cambridge Enterprise with Kidney Research UK, Cambridge Angels, Martlet. A Nov 9, 2022 expansion round (undisclosed) preceded 2024–25 clinical evaluations toward market entry.

NuvoAir (🌟 Specter ‑ Global Rank 51,732)
Virtual‑first cardiopulmonary care platform—remote spirometry, connected devices and specialty care operations—evolving to a value‑based MSO in the U.S. Founded by Lorenzo Consoli (origin story: childhood asthma). Last funding January 19, 2022 — Series A $11m (Total raised: $28.16m). Recent milestones include FDA 510(k) for the Air Next in‑home spirometer (Jan 25, 2024) and partnerships like the COPD Foundation (Dec 10, 2024).

Connectivity & Community

Patients Know Best (🌟 Specter ‑ Global Rank 10,108)
PKB’s patient‑controlled health record is the first PHR to integrate with the NHS App and, in June 2025, launched nationwide GP‑data integration, allowing adults in England to store a copy of their GP record in PKB; more than 900k patients opted in after a May soft‑release. Founder Dr. Mohammad Al‑Ubaydli (Cambridge‑trained physician; ex‑NIH staff scientist; former Advisory Board Company consultant) built PKB from a simple idea: patients should be able to own and share their complete record across settings. Last funding November 10, 2020 — Non‑Equity Assistance; separately, in January 2025 PKB secured a £6m loan from Growth Lending to scale UK deployments and international expansion.

Ocumeda (🌟 Specter ‑ Global Rank 40,034)
Tele‑ophthalmology network connecting opticians with ophthalmologists for fast, preventive eye‑care triage. The service runs a three‑step eye check‑up (optician measurements → secure transfer → specialist review), and reports 45k+ abnormalities detected early. Founded by Prof. Dr. Marcel Menke and Dr. Christian Kirr, joined by Dr. Benedikt Wiechers (CEO) and Dr. Christoph Haarburger (CTO). Last funding October 21, 2022 — Grant $150k; confirmed by Venture Kick (CHF 150k, Oct 2022). Recent momentum includes a strategic partnership with Fielmann to offer tele‑ophthalmological check‑ups in optical stores.

Untangle Grief (🌟 Specter ‑ Global Rank 59,200)
A bereavement companion app and moderated community with peer groups, expert sessions and practical guidance. Origin story: Emily Cummin met co‑founder Emma Dutton at Zinc VC; the team began as a WhatsApp‑based community before productising. Last funding $222k Equity Crowdfunding in June 2024. Mobile‑store listings outline features; HSCNI and directories list Untangle for grief support.

Lottie (🌟 Specter ‑ Global Rank 383,490)
UK later‑living marketplace pairing families with high‑quality care homes and retirement living. Founded 2021 by brothers Will & Chris Donnelly after navigating care for a relative — combining Will’s social‑care real‑estate expertise with Chris’s Verb Brands founder‑operator track. Last funding October 2023 — Series A $19.9m led by Accel with General Catalyst. Founder profiles and interviews chart rapid growth and team expansion through 2024–25.

Consumer Screening

PocDoc (🌟 Specter ‑ Global Rank 6,120)
PocDoc’s smartphone‑based microfluidic blood‑testing platform screens for cardio‑metabolic risk and pipes results into care pathways via its app and pharmacy/NHS partners. Founded by Steve Roest, Dr. Kiran Roest and Dr. Vladimir Gubala, the Cambridge team has scaled Healthy Heart Check across high‑street retail and employer sites. Last funding November 26, 2024 — Seed $6.19m (Total raised: $13m); public reports detail a record UK pre‑A in Nov 2024 with MMC, Molten, Simplyhealth Ventures and KHP Ventures.

Early Health (🌟 Specter ‑ Global Rank 22,663)
Early is building beautiful, at‑home diagnostic devices to make serious‑illness detection part of daily routines. Co‑founded by D‑J Collins (CEO) and Thomas Heatherwick (Creative Director), the company’s origin traces to late‑2022 filings; the site records a Sept 2023 pre‑seed with LocalGlobe, SoftBank Ventures Asia, Creator Fund. Last funding September 20, 2023 — Seed $4.6m (noting the site describes it as pre‑seed).

Tuli (🌟 Specter ‑ Global Rank 24,488)
Tuli partners with community pharmacies to deliver blood tests and health checks backed by UKAS‑accredited labs and a nationwide phlebotomy network, turning high‑street locations into screening hubs. Founded in 2021 by Jiawei Li and Jialu Tu (YC S21), the company expanded from COVID testing into broader diagnostics and weight‑management services. Last funding September 2021 — Seed Undisclosed.

Numan (🌟 Specter ‑ Global Rank 32,611)
Numan runs a virtual‑first clinic spanning weight loss, diagnostics, hormonal and men’s health, moving decisively toward preventive care. Founded by Sokratis Papafloratos (ex‑TrustedPlaces; early Calm investor), Last funding $60m series b extension ($30m equity led by Big Pi, $27m growth capital from HSBC).

Device Enabled Care

Adamant Health (🌟 Specter ‑ Global Rank 7,820)
Adamant’s wearable EMG measures Parkinson’s motor symptoms over multi‑day, real‑world use; new analytics convert signals into clinician‑ready reports that optimise medication timing. Spun out of University of Eastern Finland work and headquartered in Kuopio, the company is led by Paulus Carpelan and Dr. Saara Rissanen. Last funding June 13, 2022 — Seed $2.2m, with backers including Voima Ventures and COR Group. Recent news: a Gerresheimer partnership to industrialise the platform.

Bioliberty (🌟 Specter ‑ Global Rank 11,206)
Bioliberty’s soft‑robotic therapy glove pairs assistive grip with a gamified app to drive at‑home upper‑limb rehab post‑stroke, with clinician dashboards to track progress. Founded 2020 in Edinburgh by Rowan Armstrong and Ross O’Hanlon, later joined by Conan Bradley and Shea Quinn. Last funding December 4, 2023 — Grant $435k; prior £2.2m (Apr 2023) led by Archangels with Eos Advisory and Old College Capital.

Charco Neurotech (🌟 Specter ‑ Global Rank 24,786)
Charco’s CUE1 delivers vibrotactile neuromodulation to ease Parkinson’s motor symptoms — a non‑invasive approach inspired by clinical cueing research. Founded 2019 by Lucy Jung (RCA/Imperial IDE). Last funding November 16, 2021 — Seed $9,.9m; the $10m seed (Nov 2021) enabled scale‑up and a partnership with the European Parkinson’s Disease Association.

Flow Neuroscience (🌟 Specter ‑ Global Rank 386,667)
Flow’s at‑home tDCS headset pairs with a CBT‑based app for major depressive disorder, sold in Europe as a Class IIa medical device. Founded 2016 in Malmö by Dr. Daniel Månsson (clinical psychologist) and Erik Rehn (engineer). Last funding July 18, 2024 — Convertible Note; earlier funding includes a Series A (2021). Recent explainers spotlight adoption and ongoing clinical evaluation.

Diagnostics & Clinical Decision Support

Powerful Medical (🌟 Specter ‑ Global Rank 1,667)
Powerful Medical’s PMcardio® provides AI ECG interpretation at first contact — detecting STEMI/OMI and dozens of cardiac conditions — and is CE‑marked class IIb in Europe. Co‑founded by Martin Herman (CEO) and Dr. Robert Herman (CMO), the company is expanding into bedside diagnostics via platform partnerships. Last funding July 28, 2025 — Grant $46.4m.

32Co (🌟 Specter ‑ Global Rank 1,823)
32Co blends AI models with specialist‑in‑the‑loop workflows to let local dentists deliver orthodontics and sleep care without referrals. Recent moves include a first‑of‑its‑kind partnership with Dental Protection to provide members priority access to orthodontic training and risk support, and marketing materials cite “Over 1200+” satisfied practices using the platform. Founded by Dr. Sonia Szamocki (former NHS doctor & healthtech operator) in London. Last funding June 28, 2023 — Seed $2.7m.

Digistain (🌟 Specter ‑ Global Rank 2,467)
Digistain’s tumour‑profiling platform uses optical spectral imaging + AI to deliver a 10‑year recurrence‑risk score for ER+/HER2‑, Stage I–II breast cancer, aiming to reduce reliance on costly send‑out genomic assays. Originating from Imperial College London research by Dr. Hemmel Amrania and Prof. Chris Phillips, the company reports MHRA clearance and UKCA marking, with clinical validation published in early 2024. Last funding September 9, 2021 — Seed Undisclosed.

Surge (🌟 Specter ‑ Global Rank 9,813)
Surge decrypts the immune system via multi‑omics + AI; its Stabl algorithm extracts sparse, reliable biomarker signatures to power PreCyte®, a blood test that predicts post‑operative complications pre‑surgery. Founded by a cross‑European research team (with roots spanning Stanford, Harvard, Sorbonne, École Polytechnique), the Paris‑based startup is opening SurgeLab™ and scaling deployments. Last funding Mar 2024 €7.5m round led by Eurazeo with Kima, Teampact, MH Innov’.

Digital Operating Room

Medical Realities (🌟 Specter ‑ Global Rank 20,978)
VR‑first surgical‑training studio, best known for the 2016 VR‑livestreamed operation at Barts — a milestone that popularised 360°/AR learning in the operating theatre. Co‑founded by Prof. Shafi Ahmed and Steve Dann; early collaborations with filmmakers helped shape immersive modules used in UK surgical education. Last funding February 15, 2024 — Series Unknown $475k. Based in London, England, United Kingdom, Europe.

Hypervision Surgical (🌟 Specter ‑ Global Rank 34,521)
Real‑time hyperspectral imaging for the OR — using safe visible light + AI to flag perfusion and tissue boundaries, a King’s College London spin‑out now piloting with surgical teams. Co‑founded by Dr. Michael Ebner (CEO) with advisors from KCL/Imperial; added CMR Surgical founder Martin Frost to the board. Last funding June 6, 2023 — Non Equity Assistance Undisclosed. Based in London, England, United Kingdom, Europe.

Concentric Health (🌟 Specter ‑ Global Rank 64,173)
Digital consent and shared‑decision platform, replacing paper workflows with EHR‑integrations and a large consent‑content library; company figures cite 10k+ clinicians and 26k patients/week. Founded in Cardiff by Dr. Dafydd Loughran (CEO), Mr Edward St John (CMO) and Martyn Loughran (CTO). Last funding April 14, 2022 — Grant $528k (Total raised: $1.6m). Based in Cardiff, Wales, United Kingdom, Europe.

Caresyntax (🌟 Specter ‑ Global Rank 386,876)
Vendor‑neutral precision‑surgery data platform that unifies video, device and EHR signals for analytics, safety and performance — deployed across thousands of ORs (company 2024 highlights). Co‑founded by Dennis Kogan (CEO). Last funding August 15, 2024 — Series C $80m to accelerate expansion. Based in Boston, Massachusetts, United States, United States.

Digital Therapeutics

C2Care (🌟 Specter ‑ Global Rank 2,993)
C2Care’s VR‑based exposure‑therapy suite spans phobias, anxiety, addictions and eating disorders, built on CBT and delivered via clinician and patient apps. Founded in 2015 by Romain Streichemberger and Pierre Gadea after collaborating with a physician pioneering VR‑for‑phobia treatment. Last funding January 16, 2020 — Series Unknown $1.1m. Based in Sanary‑sur‑Mer / Toulon, France.

Oto (🌟 Specter ‑ Global Rank 11,929)
Oto’s tinnitus program re‑trains auditory pathways through short daily CBT‑based sessions, sleep and stress modules and optional coaching; the service is used by 300+ clinicians (company figure). Founded by Dr. Edmund Farrar, Dr. George Leidig and Dr. Jameel Muzaffar — clinicians and researchers with lived experience of tinnitus. Last funding July 14, 2022 — Seed $3,291,741 to expand access. London‑based.

Closed Loop Medicine (🌟 Specter ‑ Global Rank 31,822)
Closed Loop pairs dose‑optimised drug therapy with software as a medical device to create precision‑dosing combination products (e.g., CLM‑IN01 for insomnia). Co‑founded by executives and clinicians led by Dr. Hakim Yadi OBE in the company’s early years. Last funding November 3, 2021 — Seed $17.8m (Total: $22.9m); 2021 saw UKCA/CE designation for a device component, and Mar 2024 a strategic partnership with Teva UK. HQ London.

Inflow (🌟 Specter ‑ Global Rank 382,550)
Inflow delivers a CBT‑based ADHD program with daily micro‑lessons, habit challenges and community support; the care stack broadened via the Lina Health acquisition. Founded in 2020 by Levi Epstein, Seb Isaacs and Dr. George Sachs (clinical psychologist). Last funding January 11, 2023 — Series A $11,000,000; coverage in Jan 2023 reported a $11M Series A to scale US/UK access. HQ London.

Provider Software

Phare Health (🌟 Specter ‑ Global Rank 377)
Phare is building an AI‑native financial OS for hospitals — starting with LLM‑powered medical coding and documentation‑integrity tools to lift capture across the revenue cycle. Founded by Dr. Martin Seneviratne, Lee Kupferman and Tymor Hamamsy (ex‑DeepMind/Google Health, Stanford/NYU), the London team is positioning Phare as a real‑time financial source of truth for provider CFOs. Last funding November 22, 2023 — Seed $3.1m.

Eolas Medical (🌟 Specter ‑ Global Rank 5,499)
Eolas turns static hospital guidelines, SOPs and local pathways into trusted answers at the point of care — version‑controlled, searchable and embedded in clinical workflows. Origin story: emergency doctor Dr. Declan Kelly began building tools for his department; the product evolved into an enterprise answer engine used across multiple hospital sites. Last funding Dec 2023 $5.07m; Total funding $7.88m.

OASYS NOW (🌟 Specter ‑ Global Rank 9,810)
OASYS NOW runs GRIP, a patient‑centric clinical‑trials & health‑data platform: matching people with chronic conditions to nearby trials while giving sponsors privacy‑preserving recruitment and cohort insights. Founded in 2021 in Delft by Nima Salami and Sara Okhuijsen (with early teammate Viktor Koppenol). Last funding November 22, 2024 — Seed $1.04m (Total raised: $1.29m).

Nabla (🌟 Specter ‑ Global Rank 9,100)
Nabla’s ambient AI assistant is evolving into an agentic copilot: capturing notes, proposing medical codes, and triggering EHR commands across Epic, athenahealth and others — removing clicks from clinical workflows. Founded by Alexandre Lebrun (ex‑Wit.ai/Facebook AI), Delphine Groll and Martin Raison (ex‑FAIR/Wit.ai). Last funding June 17, 2025 — Series C $70m.

Remote Patient Monitoring

Shen.AI (🌟 Specter ‑ Global Rank 9,428)
Shen.AI’s camera‑only vitals turn a 30‑second face scan into estimates for HR, HRV, BP and stress, using rPPG + CV/ML — a device‑free RPM layer for telehealth and insurance triage. Founded by Remi Kościelny and Przemek Jaworski (MX Labs), the team is productising SDKs for third‑party apps. Last funding September 19, 2024 — Series Unknown Undisclosed (Total raised: $3.1m). HQ Tallinn, Harjumaa, Estonia, Europe.

Aiber (🌟 Specter ‑ Global Rank 23,580)
Aiber equips airline and maritime crews with an in‑cabin medical‑emergency kit + decision support, connecting to ground clinicians to avoid unnecessary diversions — RPM for the world’s most remote care settings. A University of Aberdeen spin‑out co‑founded by Anne Roberts and Dr. Alasdair Mort, Aiber piloted with Boeing and raised a £2m round with BGF, Scottish Enterprise and Equity Gap. Last funding May 12, 2022 — Series Unknown $2.4m. HQ Inverness, Scotland, United Kingdom, Europe.

Tucuvi (🌟 Specter ‑ Global Rank 35,441)
Tucuvi’s LOLA® clinical voice agent automates post‑discharge and chronic‑care calls, structuring patient speech into clinician alerts and tasks. Founded in Madrid by María González Manso and Marcos Rubio, the product is now a CE‑marked Class IIb SaMD with ISO 13485, and features in heart‑failure RPM programs like AZERCA. Last funding October 16, 2022 — Grant $2.4m (Total raised: $3.9m). HQ Madrid, Madrid, Spain, Europe.

Oura (🌟 Specter ‑ Global Rank 8,413)
ŌURA’s smart ring underpins consumer‑grade RPM for sleep, recovery and readiness, now pushing clinical integrations (e.g., Dexcom CGM collaboration) on top of a large subscription base. Founded in Oulu (2013) by Petteri Lahtela, Kari Kivelä and Markku Koskela. Last funding November 19, 2024 — $200m series d (Dec 2024) at a $5.2bn valuation. HQ Oulu, North Ostrobothnia, Finland, Europe.

Symptom Checking & Triage

XUND (🌟 Specter ‑ Global Rank 9,590)
XUND’s SaMD‑grade symptom‑assessment API powers insurer and provider triage with explainable pathways and CE‑focused governance. Recent updates centred on pre‑Series A expansion in DACH/UK and deeper EHR/partner integrations. Founded in 2018 by Tamás Petrovics, Lukas Seper and Dr. Zoltán Tarabó (Vienna/Budapest). Last funding March 5, 2025 — Seed $6.3m (total: $14.3m). HQ Vienna, Vienna, Austria, Europe.

BYON8 (🌟 Specter ‑ Global Rank 35,570)
BYON8’s “Your Health Mate” blends symptom checking with 24/7 tele‑consults, labs and health tracking, scaling from Sweden into Kenya under local licensure. Founded by the Murad brothers (Josef & Matias) with a hybrid clinician + engineering team. Last funding August 6, 2021 — Seed $1.5m (total: $2.3m). HQ Stockholm, Stockholm, Sweden, Europe.

Fleming (🌟 Specter ‑ Global Rank 37,415)
Fleming pairs AI symptom checking with tele‑visits and navigation, emerging from Medical Score within Kilo Health’s venture program. Led by co‑founders Mantas Bacevičius and Domas Pleskus, the product targets consumer‑first entry with clinician escalation. Last funding August 1, 2021 — Seed $1.42m (total: $2.87m). HQ Vilnius, Vilnius, Lithuania, Europe.

Doktor.se (🌟 Specter ‑ Global Rank 522,213)
Doktor.se runs one of the Nordics’ largest hybrid models — digital triage/chat/voice fused with a nationwide clinic network — expanding across the region. Founded in 2016 by Martin Lindman and Svante Tegnér. Last funding $223k secondary transaction Nov 2024; Total funding: $218m backed by Fiftyfive Capital., Aligned Ventures, Centripetal VC, Consensus Asset Management, and Norron Asset. HQ Stockholm, Stockholm, Sweden, Europe.

Teleconsultation

Dermanostic (🌟 Specter ‑ Global Rank 7,858)
Dermanostic’s tele‑dermatology app turns photos + short history into a specialist letter within 24 hours, issuing EU‑valid e‑prescriptions when appropriate. Origin story: co‑founders Dr. Estefanía Lang, Dr. Alice Martin, Patrick Lang and Dr. Ole Martin began solving ad‑hoc triage from friends’ images—productising an asynchronous model now used widely in Germany. Last funding June 27, 2025 — Seed $5.86m (Total raised: $7.86m). Based in Düsseldorf, North Rhine-Westphalia, Germany, Europe.

Toothfairy (🌟 Specter ‑ Global Rank 11,339)
Toothfairy’s on‑demand teledentistry connects users to UK dentists 24/7 for emergency advice, prescriptions, aligner care and preventive plans—now embedded in employer benefits via Canada Life and Unum. Founded by Dr. Deepak Singh Aulak (dentist‑turned‑founder) to bring prevention‑first dentistry to the phone. Last funding September 29, 2021 — Seed $4.02m. Based in London, England, United Kingdom, Europe.

MedicSpot (🌟 Specter ‑ Global Rank 21,011)
MedicSpot began with pharmacy‑based telemedicine kiosks (CQC‑approved) before pivoting to online GP consults and direct‑to‑consumer programs. Co‑founded by Dr. Zubair Ahmed (GP; LBS MBA). Last funding March 1, 2020 — Angel $1.91m (Total raised: $3.45m). Based in London, England, United Kingdom, Europe.

HealthHero (🌟 Specter ‑ Global Rank 388,450)
HealthHero runs a pan‑European virtual‑care platform across GP, mental health and urgent care, scaling via acquisitions like Doctorlink (UK, 2020) and Qare (France, 2021) to reach millions of covered lives. Led by co‑founder Ranjan Singh with regional leadership across UK & Europe. Last funding July 1, 2021 — Series B $82.9m (Total raised: $151m). Based in London, England, United Kingdom, Europe.

Wellness

FoodMarble (🌟 Specter ‑ Global Rank 51,697)
FoodMarble’s AIRE 2 turns home breath hydrogen & methane readings into real‑time, app‑linked insights for people managing IBS/SIBO. The Dublin team — Aonghus Shortt, Lisa Ruttledge, Peter Harte and James Brief — built the handheld sensor to bring clinically‑informed food‑response testing out of the lab and into the kitchen. Last funding April 11, 2022 — Convertible Note Undisclosed (Total raised: $8.69m). HQ Dublin, Leinster, Ireland, Europe.

NGX (🌟 Specter ‑ Global Rank 61,567)
NGX pairs a saliva DNA test with algorithmic blends to deliver personalised meal‑shake nutrition, manufactured in the UK. Founded by Jeremy Poland and Hugo Jones, NGX grew through crowdfunding and a direct‑to‑consumer community. Last funding January 17, 2023 — Equity Crowdfunding $174k (Total raised: $856k). HQ London, England, United Kingdom, Europe.

Apriwell (🌟 Specter ‑ Global Rank 105,730)
Apriwell addresses sluggish digestion & constipation via a habit‑based course and daily in‑app coaching, with complementary plant‑based formulations. Operated by Apricot Health GmbH (Berlin); public profiles attribute leadership to Alexander Puschilov (ex‑Viomedo). Last funding April 19, 2023 — Seed Undisclosed (Total raised: $3,395,970). HQ Berlin, Berlin, Germany, Europe.

ZOE (🌟 Specter ‑ Global Rank 53,438)
ZOE combines at‑home microbiome, blood‑fat and glucose testing with food‑scoring and a coaching app, leaning on King’s College London research. Co‑founded by Prof. Tim Spector OBE, Jonathan Wolf and George Hadjigeorgiou, the company is expanding in the US. Last funding July 29, 2024 — series b $15m. HQ Boston, Massachusetts, United States, United States.

Workplace Wellness

NudgeLabs (🌟 Specter ‑ Global Rank 9,897)
PeakPath (formerly NudgeLabs) combines wearable biometrics (e.g., Oura) with AI insights and 1:1 coaching to lift wellbeing across high‑performing teams. Origin story: a Nordic team led by Magnus Ljungman (CEO) built NudgeLabs through YC’s W22 before rebranding to PeakPath and focusing on enterprise rollouts. Last funding January 22, 2022 — Pre Seed $1m (Total raised: $1.76m). HQ Stockholm, Stockholm, Sweden, Europe.

Vitaance (🌟 Specter ‑ Global Rank 12,019)
Vitaance wraps employee wellbeing + insurance into a single ‘One‑Click Benefits’ platform — mental, physical and social pillars, plus group life/accident cover — with a mobile app for ongoing engagement. Founded in Spain by Sergio Alonso, Pedro Díaz and Ana Zamora, the team has drawn backing from Shilling, K Fund and others. Last funding February 10, 2023 — Seed $2.35m (Total raised: $6.28m). HQ Barcelona, Catalonia, Spain, Europe.

Syrona Health (🌟 Specter ‑ Global Rank 25,184)
Syrona’s SORA platform delivers gender‑inclusive benefits across endometriosis, fertility, pregnancy, menopause and cancer, combining virtual clinics, self‑management tools and tele‑support for employees. Founded by Anya Roy and Chantelle Bell (Cambridge‑linked scientists), Syrona is YC‑backed and integrated in employer benefit stacks. Last funding November 9, 2022 — Series Unknown Undisclosed (Total raised: $2m). HQ London, England, United Kingdom, Europe.

Wagestream (🌟 Specter ‑ Global Rank 35,680)
Wagestream’s financial‑wellbeing app adds flexible pay, savings pockets and budgeting — now extending into workplace loans via employer‑set guardrails — with major programs across the UK & US. Founded by Peter Briffett and Portman Wills, the company scaled post‑$175m series c (2022), launched Asda’s 4.7% AER savings in 2024, and secured a £300m Citi facility (2025). Last funding May 7, 2025 — Debt Financing $400.7m (Total raised: $679m). HQ London, England, United Kingdom, Europe.

Strategic Outlook

Condition companions go full-stack. Voice, wearables, and home tests are bundling into disease-specific “companion stacks” (e.g., Albert Health, Orbit Health, Kalium, NuvoAir) with payer/pharma routes and real-world deployments.
Screening shifts to pharmacies & employers. Smartphone microfluidics and retail labs (PocDoc, Tuli) plus design-led at-home devices (Early Health) and preventive virtual clinics (Numan) move diagnostics closer to daily life.
Home-first neuro & rehab. Regulated hardware + apps (Adamant, Charco, Bioliberty, Flow) turn therapy into quantified, at-home routines.
Clinical AI takes ownership of pathways. CE/MHRA-anchored tools (Powerful Medical, Digistain) and specialist-in-the-loop platforms (32Co, Surge) shift from pilots to frontline decision support.
OR “data plane.” Imaging (Hypervision), consent OS (Concentric), and vendor-neutral data unification (Caresyntax), alongside VR training (Medical Realities), standardize digital workflows in theatre.
RPM becomes software rails. Camera, voice, and wearables (Shen.AI, Tucuvi, Oura, Aiber) feed modular monitoring pipelines beyond device fleets.
Access bifurcates: APIs + tele-verticals. XUND’s triage API underpins brands like Dermanostic, Toothfairy, MedicSpot, HealthHero and hybrid networks (Doktor.se).
Connective tissue: records, communities, marketplaces. PKB’s patient-controlled PHR at NHS scale; Ocumeda’s tele-ophthalmology; Untangle’s moderated grief community; Lottie’s later-living marketplace.
DTx pairs rigor with pragmatic distribution. C2Care (VR CBT), Oto (tinnitus CBT), CLM (drug+SaMD), Inflow (ADHD) align evidence with channels and partners.
Employer stacks consolidate. PeakPath/NudgeLabs (biometrics+coaching), Vitaance (benefits+insurance), Syrona (women’s health), Wagestream (financial wellbeing) bundle measurable engagement across pillars.
Capital concentration. Funding clusters around regulated, distribution-ready rails (e.g., Oura, Caresyntax, Dermanostic, Powerful Medical, PocDoc, ZOE, PKB loan, Wagestream).

What’s next: reimbursable companion stacks; pharmacy/employer screening at scale; triage APIs beneath branded care; OR data unification; and employer benefits that braid physical, gender-specific, and financial wellbeing.

Key Takeaways

Chronic Care & Companion Apps: From point apps to evidence-based companions tied to devices/payers — Albert Health (voice-first multi-chronic), Orbit Health (Garmin-enabled Parkinson’s insights), Kalium Health (home K⁺ testing), NuvoAir (respiratory MSO).
Connectivity & Community: Patient-controlled data and targeted peer support — Patients Know Best (NHS App–integrated PHR), Ocumeda (tele-ophthalmology with in-store triage), Untangle Grief (moderated bereavement community), Lottie (later-living marketplace).
Consumer Screening: Diagnostics pushed to phone, pharmacy and home — PocDoc (microfluidic phone tests for cardio-met risk), Early Health (at-home serious-illness devices), Tuli (pharmacy blood-test hubs), Numan (preventive virtual clinic).
Device Enabled Care: Lab-grade sensing and neuromodulation at home — Adamant Health (wearable EMG for Parkinson’s), Bioliberty (soft-robotic rehab glove), Charco Neurotech (vibrotactile CUE1), Flow Neuroscience (tDCS + CBT for MDD).
Diagnostics & CDS: Faster first-contact answers — Powerful Medical (AI ECG, CE IIb), 32Co (AI + specialist-in-loop for ortho/sleep), Digistain (optical spectral breast-cancer risk), Surge (multi-omics PreCyte® for post-op risk).
Digital Operating Room: Training, vision and workflows go digital — Medical Realities (VR surgical training), Hypervision Surgical (real-time hyperspectral imaging), Concentric Health (digital consent), Caresyntax (OR data unification).
Digital Therapeutics: Software-drug combos and VR/CBT programs — C2Care (VR exposure therapy), Oto (CBT-based tinnitus), Closed Loop Medicine (precision dosing + SaMD), Inflow (CBT for ADHD).
Remote Patient Monitoring: Device-free vitals and hard-to-reach settings — Shen.AI (camera-only vitals), Aiber (in-cabin maritime/air RPM), Tucuvi (LOLA® clinical voice agent), Oura (ring-based sleep/readiness with clinical ties).
Symptom Checking & Triage: API-grade triage to hybrid care — XUND (SaMD API, DACH/UK), BYON8 (checker + 24/7 consults/labs), Fleming (AI checker + navigation), Doktor.se (Nordic digital + clinic network).
Teleconsultation: Specialist, asynchronous care at scale — Dermanostic (24-h derm letters + e-Rx), Toothfairy (on-demand teledentistry, employer benefits), MedicSpot (kiosks → online GP), HealthHero (pan-EU GP/mental/urgent via M&A).
Wellness: Personalised biomarkers and nutrition — FoodMarble (AIRE 2 breath testing for IBS/SIBO), NGX (DNA-informed meal shakes), Apriwell (habit-based GI coaching), ZOE (microbiome/blood-fat/glucose → food scores + coaching).
Workplace Wellness: Benefits, life-stage care and financial resilience — NudgeLabs/PeakPath (wearables + AI + coaching), Vitaance (“One-Click Benefits” + group cover), Syrona Health (SORA for endometriosis→menopause), Wagestream (flex pay, savings, budgeting, loans).